/Hope in Fight Against Pediatric Cancers: Allterum Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Appl. for 4A10 in Acute Lymphoblastic Leukemia
NEWS
Hope in Fight Against Pediatric Cancers: Allterum Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Appl. for 4A10 in Acute Lymphoblastic Leukemia
PRNewswire
2025/10/09Clinical Trials & Medical DiscoveriesSummary
Advancing Hope in the Fight Against Pediatric Cancers: Allterum Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for 4A10 in Acute Lymphoblastic Leukemia. Allterum Therapeutics, a clinical-stage biotechnology company dedicated to developing innovative and...